Back to Screener

Anteris Technologies Global Corp. Common Stock (AVR)

Price$9.64
Value ScoreF
Growth ScoreD
Momentum ScoreA

Favorite Metrics

Price vs S&P 500 (26W)127.20%
Price vs S&P 500 (4W)46.51%
VGM Score43.37
Market Capitalization$938.38M

All Metrics

Book Value / Share (Quarterly)$2.86
P/TBV (Annual)3.21x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-15.77%
Cash Flow / Share (Quarterly)$-0.89
Price vs S&P 500 (YTD)85.03%
Gross Margin (TTM)74.28%
Net Profit Margin (TTM)-5148.78%
EPS (TTM)$-2.21
10-Day Avg Trading Volume1.46M
EPS Excl Extra (TTM)$-2.21
EPS (Annual)$-2.55
ROI (Annual)-121.55%
Gross Margin (Annual)70.26%
Cash / Share (Quarterly)$2.91
Revenue Growth QoQ (YoY)-11.15%
ROA (Last FY)-409.38%
Revenue Growth TTM (YoY)-0.54%
EBITD / Share (TTM)$-1.94
Operating Margin (TTM)-5192.92%
Cash Flow / Share (Annual)$-1.92
P/B Ratio3.37x
P/B Ratio (Quarterly)1.94x
Net Income / Employee (Annual)$-541,100
EV / Revenue (TTM)354.35x
Net Interest Coverage (TTM)-1057.71x
ROA (TTM)-101.21%
EPS Incl Extra (Annual)$-2.55
Current Ratio (Annual)0.73x
Quick Ratio (Quarterly)20.80x
3-Month Avg Trading Volume0.99M
52-Week Price Return94.35%
Revenue / Employee (TTM)$10,600
Tangible BV / Share (Quarterly)$2.86
P/S Ratio (Annual)490.53x
Asset Turnover (Annual)0.08x
52-Week High$10.14
EPS Excl Extra (Annual)$-2.55
26-Week Price Return135.12%
Quick Ratio (Annual)0.70x
13-Week Price Return52.29%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)20.93x
Enterprise Value$655.89M
Asset Turnover (TTM)0.02x
Revenue / Employee (Annual)$11,000
Inventory Turnover (Annual)1.71x
Pretax Margin (Annual)-4925.51%
Cash / Share (Annual)$0.30
3-Month Return Std Dev65.99%
Net Income / Employee (TTM)$-547,700
ROE (Last FY)-121.56%
Net Interest Coverage (Annual)-138.88x
EPS Basic Excl Extra (Annual)$-2.55
Receivables Turnover (TTM)8.81x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-2.21
Receivables Turnover (Annual)15.94x
ROI (TTM)-64.41%
P/S Ratio (TTM)506.96x
Revenue / Share (Annual)$0.05
Tangible BV / Share (Annual)$1.74
Price vs S&P 500 (52W)69.99%
Year-to-Date Return93.19%
5-Day Price Return5.93%
EPS Normalized (Annual)$-2.55
Net Profit Margin (Annual)-4921.28%
Month-to-Date Return11.83%
EBITD / Share (Annual)$-2.50
Operating Margin (Annual)-4908.21%
LT Debt / Equity (Annual)0.00x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-2.21
P/TBV (Quarterly)1.94x
P/B Ratio (Annual)3.20x
Inventory Turnover (TTM)1.96x
Pretax Margin (TTM)-5116.15%
Book Value / Share (Annual)$1.75
Price vs S&P 500 (13W)44.04%
Beta2.21x
Revenue / Share (TTM)$0.02
ROE (TTM)-64.69%
52-Week Low$2.85
vGradeF
gGradeD
mGradeA
vgmGradeC
Show chart for

Earnings Surprise History

Q1 26-0.28est. -0.16

Analyst Recommendations

Feb 2026
Mar 2026
Apr 2026
May 2026
4.00
4.00
4.00
4.00

Industry Peers — Orthopedic & Prosthetic Devices(33)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
AVRAnteris Technologies Global Corp. Common Stock
FDA$9.64
ISRGIntuitive Surgical Inc.FBC$422.06
EWEdwards Lifesciences CorpDCC$85.96
STESTERIS plcCBC$212.35
ZBHZimmer Biomet Holdings, Inc.BCC$87.33
ALGNAlign Technology IncBCC$167.74
SNNSmith & Nephew plcBCC$30.61
MSAMine Safety IncorporatedBCC$161.30
ESTAEstablishment Labs Holdings Inc.FAB$74.31
ENOVEnovis CorporationBDC$23.78
CDRECadre Holdings, Inc.CCD$30.01

About

Anteris Technologies Global Corp develops minimally invasive medical devices for structural heart disease, with its DurAVR Transcatheter Heart Valve as the flagship product. The balloon-expandable valve treats aortic stenosis through a biomimetic design that mimics the performance of a healthy human aortic valve. The company operates primarily in the United States, with additional presence in Germany, Australia, Switzerland, and Sweden.